J&J Clinical Trials
Login
Back to search

A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma

Multiple Myeloma
Clinicaltrials.gov:
EU CTIS:
#2023-506588-32-00
EudraCT:
J&J ID:
#CR108695
Other:
#68284528MMY3002
Subscribe or share this trial
Trial overviewLocationsEligibility
Countries:
  • Australia,
  • Belgium,
  • Denmark,
  • France,
  • Germany,
  • Greece,
  • Israel,
  • Italy,
  • Japan,
  • Netherlands,
  • Poland,
  • South Korea,
  • Spain,
  • Sweden,
  • United Kingdom,
  • United States
Loading...
Turin, Italy, 10126
Uppsala, Sweden, 751 85
Melbourne, Australia, 3004
Athens, Greece, 12462
Bologna, Italy, 40138
Bristol, United Kingdom, BS2 8ED
Nantes, France, 44093
Lille, France, 59037
Poitiers, France, 86021
Montpellier, France, 34295
Liège, Belgium, B-4000
Manchester, United Kingdom, M20 4BX
Pamplona, Spain, 31008
Denver, Colorado, United States, 80218
Durham, North Carolina, United States, 27710
Rotterdam, Netherlands, 3015 CN
Murdoch, Australia, 6150
Milan, Italy, 20133
Newcastle upon Tyne, United Kingdom, NE7 7DN
Hackensack, New Jersey, United States, 07601
Jerusalem, Israel, P.O.B. 12000
Sapporo, Japan, 060-8648
Paris, France, 75475
Barcelona, Spain, 08036
Salamanca, Spain, 37007
Madrid, Spain, 28007
Madrid, Spain, 28041
Seville, Spain, 41013
Lyon, France, 69002
Salt Lake City, Utah, United States, 84112
Milan, Italy, 20132
Badalona, Spain, 08916
Toulouse, France, 31059
Warsaw, Poland, 02 776
Shibuya City, Japan, 150-8935
Kanazawa, Japan, 920 8641
Stockholm, Sweden, 141 86
London, United Kingdom, SE5 9RS
Tübingen, Germany, 72076
Fukuoka, Japan, 812 8582
Rochester, Minnesota, United States, 55905
Phoenix, Arizona, United States, 85054
Milwaukee, Wisconsin, United States, 53226
New York, New York, United States, 10065
Nagoya, Japan, 467 8602
Gliwice, Poland, 44102
Okayama, Japan, 700 8558
Melbourne, Australia, 3000
Roma, Italy, 00168
Birmingham, United Kingdom, B15 2TH
Copenhagen, Denmark, DK-2100
Adelaide, Australia, 5000
Herston, Australia, 4029
Camperdown, Australia, 2050
Seoul, South Korea, 06351
Seoul, South Korea, 03080
Ramat Gan, Israel, 74047
Lund, Sweden, 221 85
Tel Aviv, Israel, 64239
Stanford, California, United States, 94305-5623
Seoul, South Korea, 06591
Columbus, Ohio, United States, 43210
Sendai, Japan, 980 8574
Utrecht, Netherlands, 3584 CX
Ghent, Belgium, 9000
Leuven, Belgium, 3000
Hamburg, Germany, 20246
Cologne, Germany, 50924
Leipzig, Germany, 04103
Antwerp, Belgium, 2650
Dresden, Germany, 01307
Würzburg, Germany, 97080
London, United Kingdom, NW1 2BU
Kyoto, Japan, 602-8566
Cardiff, United Kingdom, CF14 4XW
Groningen, Netherlands, 9713 GZ
Baltimore, Maryland, United States, 21201
Miami, Florida, United States, 33136
Birmingham, Alabama, United States, 35294
Iowa City, Iowa, United States, 52242
Westwood, Kansas, United States, 66205
Rochester, New York, United States, 14642
Poznan, Poland, 60-569
Gdansk, Poland, 80 214
Amsterdam, Netherlands, 1081 HV
St Louis, Missouri, United States, 63110
Madison, Wisconsin, United States, 53705
New Haven, Connecticut, United States, 06520
#
More than 50 sites in this region
#
More than 10 sites in this region
#
Less than 10 sites in this region
Map pin icon representing individual study sites
Individual sites
Access detailed information on the trial:
Clinical trials information
About us
Key links
Get in touch
© Johnson & Johnson and its affiliates 2026
J&J Clinical Trials